Lupin takes 82.2% stake in Kaveri Therapeutics, licences 2 oncology assets for $1.6mn
21 July 20261 min read0 views
LI has received 332,000 common shares in Kaveri, which will advance the oncology programme through global clinical trials
Related Articles
0Business00
India's domestic air passenger traffic rises 1.44% to 8.64 crore in H1 2026; IndiGo retains market leadership
Akasa Air records the highest passenger load factor in June, while IndiGo continues to dominate the domestic market with a 64.3 per cent share
Firstpost.com
3 hours ago3
Business00
JioStar adds The Hundred rights in its kitty
JioStar has acquired the exclusive television and digital rights to broadcast The Hundred 2026 in India, adding another international cricket property...
Economictimes.indiatimes.com
3 hours ago3
Business00
EbixCash gets RBI nod for trade remittances
EbixCash gets RBI nod for trade remittances
Economictimes.indiatimes.com
3 hours ago3Business00
IKEA expands Delhi footprint with second store
IKEA expands Delhi footprint with second store
Economictimes.indiatimes.com
4 hours ago4